Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$13.27 - $18.48 $45.6 Million - $63.5 Million
-3,436,925 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$14.49 - $20.72 $250,401 - $358,062
-17,281 Reduced 0.5%
3,436,925 $55.7 Million
Q4 2020

Feb 10, 2021

BUY
$14.61 - $22.14 $265,624 - $402,527
18,181 Added 0.53%
3,454,206 $73.1 Million
Q3 2020

Nov 12, 2020

SELL
$13.67 - $17.77 $35,364 - $45,970
-2,587 Reduced 0.08%
3,436,025 $50.9 Million
Q2 2020

Aug 14, 2020

BUY
$10.89 - $21.47 $136,473 - $269,062
12,532 Added 0.37%
3,438,612 $50.6 Million
Q1 2020

May 15, 2020

SELL
$10.23 - $24.56 $239,013 - $573,819
-23,364 Reduced 0.68%
3,426,080 $40.2 Million
Q4 2019

Feb 14, 2020

SELL
$17.42 - $26.61 $13,831 - $21,128
-794 Reduced 0.02%
3,449,444 $79.9 Million
Q3 2019

Nov 14, 2019

BUY
$16.36 - $21.39 $12.1 Million - $15.8 Million
739,663 Added 27.29%
3,450,238 $63.8 Million
Q2 2019

Aug 14, 2019

BUY
$16.93 - $26.22 $8.97 Million - $13.9 Million
529,998 Added 24.31%
2,710,575 $0
Q1 2019

May 15, 2019

BUY
$23.15 - $28.34 $30.6 Million - $37.4 Million
1,320,025 Added 153.39%
2,180,577 $53.3 Million
Q4 2018

Feb 14, 2019

BUY
$22.03 - $32.01 $19 Million - $27.5 Million
860,552 New
860,552 $22.3 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $135M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.